<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=HA_antibody</id>
	<title>HA antibody - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://eln.excellgen.com/index.php?action=history&amp;feed=atom&amp;title=HA_antibody"/>
	<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=HA_antibody&amp;action=history"/>
	<updated>2026-10-18T03:26:34Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://eln.excellgen.com/index.php?title=HA_antibody&amp;diff=16461&amp;oldid=prev</id>
		<title>Paul.xu: Created page with &quot;Example 1 Production of Clones R 3F10, R 3A12 and R 6D12 HA peptide preparation  The following peptides were synthesized:  Bio-C-HA (acetyl-YPYDVPDYAGSGSK (ε-biotinoyl)-amide...&quot;</title>
		<link rel="alternate" type="text/html" href="https://eln.excellgen.com/index.php?title=HA_antibody&amp;diff=16461&amp;oldid=prev"/>
		<updated>2017-09-15T04:07:55Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;Example 1 Production of Clones R 3F10, R 3A12 and R 6D12 HA peptide preparation  The following peptides were synthesized:  Bio-C-HA (acetyl-YPYDVPDYAGSGSK (ε-biotinoyl)-amide...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Example 1 Production of Clones R 3F10, R 3A12 and R 6D12 HA peptide preparation&lt;br /&gt;
&lt;br /&gt;
The following peptides were synthesized:&lt;br /&gt;
&lt;br /&gt;
Bio-C-HA (acetyl-YPYDVPDYAGSGSK (ε-biotinoyl)-amide) (SEQ ID NO: 2) Bio-N-HA (biotinoyl-ε-Aca-SGSGYPYDVPDYA-amide) (SEQ ID NO: 3) KLH-MPS-CUZU-HA-C KLH-MPS-CUSU-HA-N Immunization of small mammals&lt;br /&gt;
&lt;br /&gt;
Lou/C rats were immunized intraperitoneally with KLH-coupled HA peptide according to the following scheme:&lt;br /&gt;
&lt;br /&gt;
For the primary immunization the animals were injected with 50 μl KLH-coupled HA peptide in complete Freund&amp;#039;s adjuvant.&lt;br /&gt;
&lt;br /&gt;
Further immunizations were carried out with 50 μg KLH-coupled HA peptide in incomplete Freund&amp;#039;s adjuvant.&lt;br /&gt;
&lt;br /&gt;
Fusion&lt;br /&gt;
&lt;br /&gt;
The subsequent fusion of the spleen cells of the Lou/C rats was carried out using mouse P3x63-Ag8,653 in the presence of PEG according to Krammer et al (1990) Hybridoma 9, 309-317.&lt;br /&gt;
&lt;br /&gt;
Selecting the clones&lt;br /&gt;
&lt;br /&gt;
Screening scheme:&lt;br /&gt;
&lt;br /&gt;
1st Screen&lt;br /&gt;
&lt;br /&gt;
An SA-coated microtitre plate (MTP) was coated with 1 μg/ml Bio-C-HA or Bio-N-HA, hybridoma supernatants were used undiluted and added to the coated MTP, the bound antibodies were detected with the aid of anti-rat-POD conjugate/TMB substrate. 2nd Screen&lt;br /&gt;
&lt;br /&gt;
A maxisorb MTP was coated with HA-tagged GST (1 μl/ml in carbonate buffer), the hybridoma supernatants selected in the 1st screen were again used undiluted and added to the coated MTP, the bound antibodies were detected with the aid of anti-rat-POD conjugate/TMB substrate. 3rd/4th Screen&lt;br /&gt;
&lt;br /&gt;
BIACORE® measurements were carried out with an analogous coating. Result&lt;br /&gt;
&lt;br /&gt;
5 clones with the highest affinity and the longest half-time of dissociation were selected with the aid of plasmon resonance in the BIACORE® system. They were named R 3F10, R 3A12, R 6D12, R 4H10 and M5B9. The affinity was only slightly different depending on the biotinoylated position of the peptides (C-terminus of N-terminus cf. FIG. 1).&lt;br /&gt;
&lt;br /&gt;
The clones R 3F10, R 3A12 and R 6D12 were established as cell lines. They exhibit a good growth and a stable antibody production, and the antibodies that are produced have a 10-fold to 100-fold higher affinity than the monoclonal antibodies of the prior art 12CA5 and anti-HA BabCo.&lt;br /&gt;
&lt;br /&gt;
The monoclonal antibody produced by hybridoma R 3A12 deposited at the “Deutsche Sammlung für Mikroorganismen und Zellkulturen” under Accession No. DSM ACC2286 (08.10.1996).&lt;br /&gt;
[[Category:Antibodies]]&lt;/div&gt;</summary>
		<author><name>Paul.xu</name></author>
	</entry>
</feed>